Abveris is a contract lab discovering monoclonal antibodies for reagent and therapeutic purposes. Using proprietary engineered in vivo systems, Abveris delivers hybridomas producing murine mABs to targets that cannot be found in natural in vivo systems.
Delivery of custom-screened monoclonal hybridoma cell lines producing IgG monoclonal antibodies in tight timelines.
The service component is important to us.
The limiting factor in most in vivo antibody discovery platforms is the diversity of the immune response of the host animal. Abveris uses a proprietary rodent that has been engineered to express a more diverse antibody repertoire than regular animals. This enables the discovery of antibodies with specificities that cannot be found in other in vivo systems.
Our specialty! We screen for ideal PK/ADA reagents targeting IgG’s and funky molecules alike. Rapid delivery available.
Rapid discovery of diverse panels of mAbs custom screened to your specifications.
DNA immunization, flow cytometry screening and other options are available.